Lidings Experts Speak at Pharmaceutical Law Conference

Lidings’ Corporate and M&A practice Associate Julia Kuzmenko and Intellectual Property practice Associate Anna Kuminova will speak at the annual conference entitled Pharmaceuticals — 2019: Legal Aspects. The event organized by will take place in Moscow on April 11th at the Marriott Royal Aurora hotel.

Regulating and controlling authorities, business’ representatives and legal counsels focused on advising companies from the pharmaceuticals sector will gather together to discuss current regulation of the life sciences industry including analysis of recent reforms and consideration of governmental initiatives aimed at stimulating the segment development.

Julia Kuzmenko focused on advising firm’s clients on all aspects of corporate law and M&A transactions particularly involving pharmaceuticals and healthcare companies will make a special presentation dedicated to the topical issues of price formation in the pharmaceutical market.

Anna Kuminova specializing on advising firm’s clients on the issues of protection and enforcement of intellectual property rights, particularly on representing interests of the pharmaceuticals and healthcare companies in trademark and patent disputes, will deliver a speech on protecting the rights of producers of original drugs to pharmaceutical patents in the EEU and the CIS countries.

Lidings is a leading legal advisor in Russia, acting as an expert in the statutory regulation of the pharmaceutical industry. The firm’s clients are recognized leaders of the pharmaceutical market, such as AstraZeneca, Boehringer Ingelheim, Merck, Ipsen Pharmaceuticals, Astellas Pharma, Mallinckrodt Pharmaceuticals, Mylan, Sanofi and many others. The firm frequently initiates and supports major international conferences devoted to issues most essential for the pharmaceutical industry in Russia and abroad. Lidings’ experts act as speakers and moderators in discussions on legal support of pharmaceutical companies doing business in the Russian Federation.

For more information on the conference, please visit the event’ official website.